Tue, December 6, 2022

Charles Duncan Downgraded (AVXL) to Hold and Decreased Target to $11 on, Dec 6th, 2022

Charles Duncan of Cantor Fitzgerald, Downgraded "Anavex Life Sciences Corp." (AVXL) to Hold and Decreased Target from $16 to $11 on, Dec 6th, 2022.

Charles, nor any peers, have made any analyst calls on AVXL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30